UAE capital mandates booster shot for Sinopharm Covid-19 vaccine recipients

The capital of the United Arab Emirates on Sunday ordered all residents who received the Chinese state-backed Sinopharm coronavirus vaccine over six months ago to get a booster shot by September 20

Sinopharm Covid-19 vaccine
(Photo: Bloomberg)
AP Dubai
2 min read Last Updated : Aug 29 2021 | 7:50 PM IST

The capital of the United Arab Emirates on Sunday ordered all residents who received the Chinese state-backed Sinopharm coronavirus vaccine over six months ago to get a booster shot by September 20, adding that recipients of other vaccines do not need the third dose.

The UAE became the first country worldwide to formally offer the booster regimen earlier this year, following reports of Sinopharm recipients seeking the third shot amid concerns about an insufficient antibody response.

Abu Dhabi, which imposed some of the region's most stringent vaccine restrictions this summer, hardened its stance on Sunday, saying that those who received two doses of Sinopharm will no longer be able to access places like malls, schools and gyms without a third booster shot.

The new rule adds to growing questions over the coronavirus protection offered by China's Sinpoharm vaccine.

Aside from basic efficacy numbers, the Chinese manufacturer has released very little public data about its vaccine, prompting criticism for its lack of transparency. Nonetheless, the shot is at the heart of China's own mass immunization campaign and became the linchpin of the UAE's rollout, among the world's fastest per capita.

At first, Abu Dhabi exclusively used Sinopharm for its rollout, but in recent months started to offer Pfizer-BioNTech as well.

Across the country, the majority of low-paid workers from Africa, Southeast Asia and the Middle East who power the UAE's economy received the Sinopharm vaccine as the nation raced toward a swift reopening.

Infections in the UAE have gradually declined from peaks reached in January but daily counts of new cases still hover at around 1,000 a day, far above last year's levels, even as over 75 per cent of the country's population has received both vaccine doses.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :UAECoronavirus VaccineChina

First Published: Aug 29 2021 | 7:50 PM IST

Next Story